Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 166 of 1,261

  1. US 11779554

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  2. US 11780904

    Method of producing recombinant high molecular weight vWF in cell culture

    Takeda Pharmaceutical Company Limited · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  3. US 11780907

    Human antibodies to influenza hemagglutinin

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  4. US 11779570

    Method for inhibiting dengue virus infection

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  5. US 11779665

    Electrochemical flash fluorination and radiofluorination

    The Regents of the University of California · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  6. US 11779635

    Subcutaneous administration of ADAMTS13

    Takeda Pharmaceutical Company Limited · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  7. US 11780930

    CD38 modulating antibody

    BLACK BELT THERAPEUTICS LIMITED · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  8. US 11780837

    CXCR4 inhibitors and uses thereof

    X4 Pharmaceuticals, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  9. US 11779633

    Glucagon-like peptide 1 receptor agonists and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  10. US 11780931

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  11. US 11779578

    IRAK degraders and uses thereof

    Kymera Therapeutics, Inc. · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  12. US 11780828

    Contraceptive compounds and methods

    Regents of the University of Minnesota · Granted Oct 10, 2023 · Expires Oct 5, 2043

    granted

  13. US 2023312523

    NEAR-INFRARED CYANINE DYES AND CONJUGATES THEREOF

    BRACCO IMAGING SPA [IT] · Granted Oct 5, 2023 · Expires Sep 30, 2043

    granted

  14. US 11773148

    Tau peptide immunogen constructs

    UNITED NEUROSCIENCE · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  15. US 11771743

    Methods for preventing or treating allergy by administering an IL-4R antagonist

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  16. US 11773143

    Conformational epitopes in respiratory syncytial virus G protein central conserved region

    The Regents of the University of California · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  17. US 11773157

    Compositions and methods for treating and preventing Staphylococcus aureus infections

    XBIOTECH INC. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  18. US 11771664

    Toxic aldehyde related diseases and treatment

    Aldeyra Therapeutics, Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  19. US 11771737

    Treating or preventing adverse liver conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  20. US 11771723

    Bifidobacterium longum NCIMB 41676

    PrecisionBiotics Group Limited · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  21. US 11773119

    Prodrugs of pyridone amides useful as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  22. US 11771751

    Streptococcal GlcNAc-lacking glycopolypeptides, cell wall carbohydrates, streptococcus vaccines, and methods for making and using them

    The Regents of the University of California · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  23. US 11771748

    Methods for treating tumor-induced osteomalacia

    Ultragenyx Pharmaceutical Inc. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

  24. US 11771667

    Methods of administering solriamfetol to lactating women

    AXSOME MALTA LTD. · Granted Oct 3, 2023 · Expires Sep 28, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.